bladder cancer
A. Menarini Gets European Rights to Nucleix Bladder Cancer Test
The CE-marked and FDA-cleared test analyzes disease-specific changes in 15 DNA methylation markers in urine using qPCR.
Informed Genomics, NHS to Study Use of Urine-Based Bladder Cancer Test
Studies planned for this year will be used to evaluate the accuracy of Informed Genomics' Galeas Bladder test and further studies are planned for early 2025.
Bladder Cancer Genomes Reveal Treatment Response-Related Mutations in Driver Gene
Researchers linked ERCC2 mutations to broader somatic mutation and treatment response patterns when they analyzed tumor genome sequences from hundreds of bladder cancers.
Chemically Induced Bladder Cancer Risk Influenced by Gut Microbe Metabolism, Study Finds
Researchers identified gut microbial species involved in metabolizing a carcinogen linked to bladder cancer formation in a mouse model.
Owkin Expands Into Western Europe With Nine Precision Medicine Partnerships
The firm will employ its machine learning-enabled diagnostic and drug discovery tools in nine centers across Germany, Austria, and Switzerland.
Apr 5, 2024
Nov 27, 2023
Mar 24, 2023
Feb 15, 2023